Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
Lisa M Niswander, Joseph P. Loftus, Élodie Lainey, Aurélie Caye‐Eude, Morgane Pondrom, David A. Hottman, Ilaria Iacobucci, Charles G. Mullighan, Nitin Jain, Marina Konopleva, Hélène Cavé, André Baruchel, Pierre‐Simon Rohrlich, Sarah K. Tasian
Abstract
Not available.
Topics & Concepts
PonatinibRuxolitinibMedicineLymphoblastic LeukemiaPhiladelphia chromosomeCancer researchInternal medicineOncologyLeukemiaGeneticsMyelofibrosisDasatinibChromosomal translocationBiologyImatinibMyeloid leukemiaGeneBone marrowAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsChildhood Cancer Survivors' Quality of Life